A patient requires mild cholinomimetic stimulation following surgery. Physostigmine and bethanechol in small doses have significantly different effects on which of the following?
**Core Concept**
Physostigmine and bethanechol are both cholinomimetic agents, but they have different mechanisms of action and effects on the muscarinic and nicotinic receptors, leading to distinct clinical outcomes.
**Why the Correct Answer is Right**
Bethanechol is a direct-acting muscarinic receptor agonist, which means it directly stimulates the muscarinic receptors in the smooth muscle of the gastrointestinal tract, bladder, and blood vessels, leading to increased smooth muscle contraction. Physostigmine, on the other hand, is an anticholinesterase inhibitor that increases the concentration of acetylcholine in the synaptic cleft by inhibiting its breakdown, thereby indirectly stimulating both muscarinic and nicotinic receptors. In small doses, physostigmine preferentially stimulates nicotinic receptors in the central nervous system, which can lead to increased salivation, sweating, and vasodilation.
**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect because both physostigmine and bethanechol can stimulate muscarinic receptors, but through different mechanisms.
**Option B:** Incorrect because the question is asking for a specific effect, and there is no indication that either drug has a significant effect on the cardiovascular system in small doses.
**Option C:** Incorrect because both drugs can stimulate smooth muscle contraction, but the mechanism of action is different.
**Clinical Pearl / High-Yield Fact**
When using cholinomimetic agents, it's essential to note that direct-acting agonists like bethanechol can cause more pronounced muscarinic effects, while indirect-acting agonists like physostigmine can cause more central nervous system stimulation.
**Correct Answer:** C. The muscarinic and nicotinic receptors.